Carlos Méndez Mangana*, Jorge Fernández-Engroba, Anton Barraquer Kargacin, Maximiliano Olivera, Rafael Ollero Martí, Santiago Abengoechea and Rafael I Barraquer
Centro de Oftalmología Barraquer and Institut Universitari Barraquer, Universitat Autònoma de Barcelona, Barcelona, Spain
*Corresponding Author: Carlos Méndez Mangana, Centro de Oftalmología Barraquer and Institut Universitari Barraquer, Universitat Autònoma de Barcelona, Barcelona, Spain.
Received: March 25, 2021; Published: May 17, 2021
Background: Since the COVID-19 pandemic began ophthalmological symptoms such as conjunctivitis, nodular episcleritis and retinal changes have been reported. Hypercoagulability has played a major role in morbidity and mortality in patients with COVID-19.
Case Presentation: A 72-year-old man without any relevant risk factors in his medical history presented cough, high fever (39 - 40ºC) and myalgia. NADAL® COVID-19 IgG/IgM test was carried out with a positive result for COVID-19 after 20 days since the onset of symptoms. After 25 days since the beginning of the general and respiratory symptoms, the patient presented a painless gradual loss of vision in the left eye. The posterior segment presented clear signs of inferior macular Branch Retinal Vein Occlusion (BRVO) as well as numerous retinal hemorrhages and cotton wools along the inferior macular branch vein and macular edema.
Conclusion: Our patient suffered a BRVO in his left eye. Therefore, since our patient does not present any other risk factor beyond COVID infection we suggest that SARS-CoV-2 may lead to retinal venous pathology.
Keywords: Branch Retinal Vein Occlusion; COVID-19; Hypercoagulability; SARS-CoV-2; Vascular Pathology
Citation: Carlos Méndez Mangana., et al. “COVID-19 and Vascular Pathology: Branch Retinal Vein Occlusion Case Report". Acta Scientific Clinical Case Reports 2.6 (2021): 17-19.
Copyright: © 2021 Carlos Méndez Mangana., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.